induction of thymic lymphosarcoma and mammary adenocarcinomas in rats by oral administration of the antitumor agent, 4 (5)-(3,3-dimethyl-1-triazeno) imidazole-5 (4)-carboxamide.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples